PIVOT: Pneumatic Retinopexy vs. Vitrectomy for Primary RRD

Written by: Maxwell S. Stem, MD Hillier RJ, Felfeli T, Berger AR, et al. The Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT). Ophthalmology. 2019;126(4):531-539. The optimal management of a primary, uncomplicated rhegmatogenous retinal detachment (RRD) is a matter of some debate among vitreoretinal surgeons.  Recently, Hillier […]

Anti-VEGF Therapy and Associated Risk of Serious Cardiovascular Events

Written by: Judy J. Chen, MD Dalvin LA, Starr MR, AbouChehade JE, et al. Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy with Risk of Stroke, Myocardial Infarction, and Death in Patients with Exudative Age-Related Macular Degeneration. JAMA Ophthalmol. 2019;137(5):483-490. Ever since intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents became the mainstay of […]

Protocol V Summary

Written by: Judy Chen, MD Baker CW, Glassman AR, Beaulieu WT, et al. Effect of Initial Management of Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial. JAMA 2019 Apr 29 [Epub ahead of print]. […]